Would be interesting to follow up the cohort, as I am sure they will be, but things to consider are as follows:
1. 2/3 of the cases were amongst people that were not vaccinated or had had 1 dose of the vaccine - Unvaccinated clearly having a higher chance of catching the disease.
2. Amongst the 1/3 of the people that got COVID even whilst being vaccinated, the WHO effectiveness data has Sinopharm's effectiveness against hospitalization at 80% - so hopefully in this cohort, we will see 80 percent of them not requiring hospitalization which is good news if the cohort that got infected are followed up, which hopefully they will be.
Hard to make conclusions regarding restrictions etc without knowing a little bit more than what we do know so far, especially as that WHO document states that >60 data is still needed, which we should be getting with ongoing trials. Good to see a responsive government going fast as opposed to twiddling their thumbs, us folk in the UK have no idea what that feels like.